Corporate ActionMay 15, 2026, 04:37 PM
Silexion Therapeutics to Raise $1.0M via Warrant Inducement
AI Summary
Silexion Therapeutics Corp entered an inducement offer letter agreement with certain warrant holders. This agreement facilitates the exercise of 1,995,092 existing warrants at a reduced price of $0.50 per share, expected to generate approximately $1.0 million in gross proceeds. In consideration, the company will issue new Series C and Series D warrants to purchase up to 3,990,184 ordinary shares, also at an exercise price of $0.50 per share. The net proceeds will be used for general corporate purposes.
Key Highlights
- Holders to exercise 1,995,092 existing warrants for cash.
- Reduced exercise price for existing warrants set at $0.50 per share.
- Expected gross proceeds of approximately $1.0 million from warrant exercise.
- Company to issue new warrants for up to 3,990,184 ordinary shares.
- New warrants (Series C and D) have an exercise price of $0.50 per share.
- Placement agent H.C. Wainwright & Co. to receive 7.0% cash fee and 1.0% management fee.
- Placement agent also to receive warrants for 139,656 ordinary shares at $0.625.
- Net proceeds designated for general corporate purposes.
Price Impact
More from SLXN